The sustainability of primary care is currently facing a critical inflection point, as practitioners and policymakers grapple with a funding model that many argue is no longer fit for purpose. At the heart of the debate is the GP reimbursement scheme, a complex system of payments designed to balance patient access with quality of care, but which is increasingly viewed as a source of systemic instability.
For those operating within the United Kingdom’s National Health Service (NHS), the tension has escalated beyond mere administrative disagreement. The conversation has shifted toward collective action—the strategic use of unified professional pressure to force a fundamental redesign of how general practice is funded, and managed. This movement is driven by a workforce facing unprecedented burnout and a reimbursement structure that critics say fails to account for the actual cost of delivering modern medicine.
Central to this struggle is the role of Primary Care Networks (PCNs), the organizational clusters intended to integrate services. However, the emergence of “PCN variation”—the disparity in how funding is utilized and how services are delivered across different networks—has created a fragmented landscape of care. Understanding these mechanisms is essential for any healthcare stakeholder looking to grasp why the current primary care crisis is as much about accounting as it is about clinical capacity.
Unpicking the GP Reimbursement Scheme
To understand the current unrest, one must first understand the architecture of GP payment. In the UK, the majority of practices operate under the General Medical Services (GMS) contract. This is primarily a “capitation-based” system, meaning practices receive a core payment based on the number of patients on their list, adjusted for age, gender, and morbidity (the “Carr-Hill Formula”).
Supplementing this core funding is the Quality and Outcomes Framework (QOF), a voluntary incentive scheme that rewards practices for achieving specific clinical targets, such as blood pressure control in hypertensive patients or smoking cessation milestones. While intended to drive clinical excellence, many physicians now argue that QOF encourages “tick-box medicine,” prioritizing measurable metrics over complex, holistic patient care.
The financial pressure stems from the fact that while patient complexity has risen, the per-patient funding has not kept pace with inflation or the increasing demands of multi-morbidity management. According to the British Medical Association (BMA), the gap between the cost of running a practice and the available reimbursement has forced many partners to subsidize their clinics from their own pockets or face insolvency.
The Complexity of PCN Variation
Introduced in 2019, Primary Care Networks (PCNs) were designed to move the NHS away from isolated practices toward a more collaborative model. A PCN typically consists of a group of practices covering a population of 30,000 to 50,000 patients. The goal was to provide a “neighborhood” approach to health, integrating pharmacists, social prescribers, and physiotherapists into the primary care team.
However, this has led to a phenomenon known as PCN variation. This variation manifests in several ways:
- Staffing Disparities: Through the Additional Roles Reimbursement Scheme (ARRS), the NHS provides funding for new roles. Yet, some PCNs successfully recruit a full suite of clinicians, while others struggle to find candidates, leaving a gap in service delivery despite having the funding available.
- Resource Allocation: Because PCNs have a degree of autonomy in how they spend their budgets, two networks in similar demographic areas may offer entirely different services, leading to a “postcode lottery” for patient care.
- Leadership Strain: The burden of managing a PCN often falls on a “Clinical Director”—usually a GP who is already working full-time. This creates a variation in the quality of network management based on the individual capacity of that leader.
This variation undermines the original intent of the PCN model. Instead of a standardized lift in care quality, the system has produced a patchwork of efficiency and failure, where the most struggling practices are often in the networks least equipped to support them.
Will Collective Action Work?
When reimbursement schemes fail to meet operational costs and organizational structures like PCNs create more bureaucracy than benefit, professional bodies often turn to collective action. In the context of general practice, this rarely looks like a traditional “walk-out” strike, as the ethical obligation to patient safety makes total cessation of service nearly impossible.
Instead, collective action in primary care typically involves “work-to-rule” strategies or the targeted refusal to implement new, unfunded mandates. The goal is to demonstrate that the system cannot function if practitioners are expected to absorb the cost of systemic failure. The BMA has frequently advocated for a “fair contract” that includes a meaningful increase in core funding and a simplification of the reimbursement model.
The effectiveness of such action depends on the level of unity among practitioners. Because GPs are often independent contractors rather than employees, organizing a cohesive front is challenging. However, as the crisis in patient access becomes a prominent political issue, the leverage of the medical workforce has increased. The argument is simple: without a sustainable reimbursement scheme, the workforce will continue to shrink, and the “front door” of the NHS will effectively close.
Key Stakeholders and Their Impact
| Stakeholder | Primary Concern | Potential Outcome of Reform |
|---|---|---|
| GP Partners | Financial viability and burnout | Reduced personal financial risk and sustainable workloads |
| Patients | Access to appointments and continuity of care | More consistent service delivery regardless of PCN location |
| NHS England | Cost containment and population health targets | More efficient resource allocation and reduced A&E pressure |
| ARRS Staff | Job security and integration into teams | Clearer clinical pathways and better professional support |
The Path Forward: What Happens Next?
The resolution of the current crisis likely lies in a move away from the rigid, target-driven nature of QOF and toward a more flexible, needs-based funding model. Experts suggest that reimbursement should be tied more closely to the actual cost of delivery in specific regions, rather than a national average that ignores local deprivation and health inequalities.
addressing PCN variation requires a more centralized support structure for Clinical Directors and a more strategic approach to the ARRS recruitment process to ensure that the “Additional Roles” actually reach the patients who need them most. The transition from “competition” between practices to “collaboration” within networks can only succeed if the financial incentives are aligned with the clinical goals.
The next critical checkpoint will be the upcoming contract negotiations between the BMA and the government. These discussions will determine whether the reimbursement scheme is fundamentally overhauled or merely patched with temporary subsidies. For the global medical community, the UK’s experiment with PCNs and capitation-based funding serves as a vital case study in the dangers of underfunding the primary care foundation of a national health system.
Do you believe that collective action is the most effective way to secure healthcare funding, or should the focus remain on legislative reform? We invite health professionals and policymakers to share their perspectives in the comments below.